- Intravesical therapy of urinary bladder tumours2014 | First Faculty of Medicine
- Complications of BCG intravesical therapy - BCGitis2019 | Faculty of Medicine in Hradec Králové
- First results combined intravesical therapy with BCG vaccine and interferon alpha 2b in recurrent superficial bladder tumorPublication without faculty affiliation
- What to do during Bacillus Calmette-Guerin shortage? Valid strategies based on evidence2018 | Second Faculty of Medicine
- Interstitial Cystitis - Its Diagnostic and Treatment2005 | First Faculty of Medicine
- Interstitial Cystitis - Its Diagnostic and Treatment2005 | Faculty of Physical Education and Sport
- BCG - history, method principe, indication, effectivity, dosage2019 | Faculty of Medicine in Hradec Králové
- Smoking Reduces the Efficacy of Intravesical Bacillus Calmette-Guerin Immunotherapy in Non-muscle-invasive Bladder Cancer2012 | Second Faculty of Medicine
- T1 High-grade Bladder Cancer: The Search for the Optimal Management Continues2018 | Second Faculty of Medicine
- The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non-muscle-invasive bladder cancer: A network meta-analysis2023 | Second Faculty of Medicine
- Prevention of bladder cancer incidence and recurrence: tobacco use2018 | First Faculty of Medicine
- Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancer2017 | Second Faculty of Medicine
- Hexyl Aminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis and Follow-up of Patients with Non-Muscle-invasive Bladder Cancer: A Critical Review of the Current Literature2013 | Second Faculty of Medicine
- Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients +12021 | Second Faculty of Medicine, First Faculty of Medicine
- Stratification of Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies2021 | Second Faculty of Medicine